|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.05.26 - 07:00
|
Neuren Pharmaceuticals Q1 2026: DAYBUE sales soar (Fool)
|
|
|
Neuren Pharmaceuticals posted a strong Q1 2026, with DAYBUE net sales and royalty income both rising more than 20% year-on-year.
The post Neuren Pharmaceuticals Q1 2026: DAYBUE sales soar appeared first on The Motley Fool Australia....
|
|
|
|
|
|
|
|
|
|
|
|
|
07.04.26 - 02:12
|
Summerset Group Q1 2026 sales rise on robust demand (Fool)
|
|
|
Summerset Group grows Q1 2026 occupation right sales by 26% as demand for new and resale units remains strong.
The post Summerset Group Q1 2026 sales rise on robust demand appeared first on The Motley Fool Australia....
|
|
|
|
|
|
|
|
|
|
|
|
|
|